Investigational small-molecule drug selectively suppresses constitutive CYP2B6 activity at the gene transcription level: physiologically based pharmacokinetic model assessment of clinical drug interaction risk (Q39012813)
Jump to navigation
Jump to search
scientific article published on 21 March 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Investigational small-molecule drug selectively suppresses constitutive CYP2B6 activity at the gene transcription level: physiologically based pharmacokinetic model assessment of clinical drug interaction risk |
scientific article published on 21 March 2014 |
Statements
1 reference
Investigational small-molecule drug selectively suppresses constitutive CYP2B6 activity at the gene transcription level: physiologically based pharmacokinetic model assessment of clinical drug interaction risk (English)
1 reference
Maciej J Zamek-Gliszczynski
1 reference
Michael A Mohutsky
1 reference
Jessica L F Rehmel
1 reference
Alice B Ke
1 reference
21 March 2014
1 reference
1 reference
42
1 reference
6
1 reference
1008-1015
1 reference
Identifiers
1 reference
1 reference